Skip to content
Open access · OA via Europe PMC

Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm.

Arafat AMA, Soliman SMA, Elfandy H, Othman MO, Elsayed W, Lotfy MM, Ebrahim NAA.

World journal of transplantation · 2026

Abstract

Pediatric solid organ and hematopoietic stem cell transplant recipients paradoxically experience accelerated immune aging despite chronological youth, establishing a paradigm with profound implications for cancer risk and long-term outcomes. This comprehensive review synthesizes current evidence demonstrating how transplantation-related factors, anti-thymocyte globulin-mediated T cell depletion, cytomegalovirus reactivation, chronic immunosuppression, and thymic dysfunction, induce premature immunosenescent phenotypes. These processes converge to generate T cell populations exhibiting CD28 loss, killer cell lectin-like receptor G1 positivity, telomere(definition) attrition, and functional exhaustion characteristic of elderly individuals. Concurrently, inflammaging(definition) pathways and senescence(definition)-associated secretory phenotypes establish pro-tumorigenic microenvironments. Consequently, pediatric recipients demonstrate 4- to 20-fold elevated cancer incidence, with standardized incidence ratios for post-transplant lymphoproliferative disease exceeding 200 in some cohorts. Beyond hematological malignancies, significant increases in solid tumors suggest fundamental immunosurveillance failure. Emerging biomarkers including flow cytometric senescence panels, telomere length measurement, and epigenetic clocks enable personalized risk stratification. Therapeutic horizons encompass senolytic agents, checkpoint inhibitor modulation, thymic regeneration strategies, and metabolic interventions targeting aging pathways. This paradigm shift necessitates reconceptualizing pediatric transplantation through the aging lens, integrating precision medicine approaches that balance graft survival, immune competence preservation, and cancer prevention in this vulnerable population.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.5500/wjt.v16.i2.117357
Canonical
link ↗
Fetched
2026-07-01 MST

Cite this

APA
AMA, A., SMA, S., H, E., MO, O., W, E., MM, L., &amp; NAA., E. (2026). Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm. <em>World journal of transplantation</em>. https://doi.org/10.5500/wjt.v16.i2.117357
Vancouver
AMA A, SMA S, H E, MO O, W E, MM L, et al. Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm. World journal of transplantation. 2026. doi:10.5500/wjt.v16.i2.117357.
BibTeX
@article{arafat2026Immuno, title = {Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm.}, author = {Arafat AMA and Soliman SMA and Elfandy H and Othman MO and Elsayed W and Lotfy MM and Ebrahim NAA.}, journal = {World journal of transplantation}, year = {2026}, doi = {10.5500/wjt.v16.i2.117357}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings